Endovascular Technologies, LLC — Bossier City, Louisiana

Endovascular Technologies, LLC is a clinical research site located in Bossier City, Louisiana, United States 71111.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Endovascular Technologies, LLC has participated in 2 clinical trials.

Therapeutic areas: Peripheral Arterial Disease, Peripheral Vascular Disease, Artery Disease, Peripheral.

Sponsors: SurModics, Inc., Mercator MedSystems, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bossier City

Browse all research sites in Louisiana · View every site in Bossier City

• Grace Research
• GSK Investigational Site
• Research Site
• Pfizer Investigational Site
• Grace Research, LLC-Bossier City-51040
• Willis-Knighton Bossier Medical Center
• Willis-Knighton Medical Center
• Investigator Site - Bossier
• Grace Research - Bossier
• Cardiovascular Consultants
• Bossier Optical Inc.

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Endovascular Technologies, LLC?

Endovascular Technologies, LLC has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Endovascular Technologies, LLC conducted?

Endovascular Technologies, LLC has 2 clinical trials on record. Their work covers Peripheral Arterial Disease, Peripheral Vascular Disease, Artery Disease, Peripheral.

Is Endovascular Technologies, LLC accredited by Crixeo Clinical Trials?

Endovascular Technologies, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Endovascular Technologies, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.